Claim Missing Document
Check
Articles

Found 23 Documents
Search

Nutraceuticals in Diabetes Management Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed
International Journal of Integrative Sciences Vol. 3 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i4.8158

Abstract

Nutraceuticals, a suitcase of "food" and "pharmaceuticals," represent a blooming field in the administration of diabetes. With the all-encompassing predominance of diabetes reaching its disquieting dimensions, there is a growing need for complete approaches to complement normal analyses. Nutraceuticals, including bioactive compounds derived from snack beginnings, have attracted attention for their potential to prevent and treat diabetes.Polyphenols in various products, legumes, and teas have shown antagonistic diabetic properties by modulating sweet substance absorption and insulin sensitivity. curcumin fatty Curcumin, a bioactive compound in turmeric, demonstrates antagonistic-instigative and antioxidant properties, providing improved glycemic control. Omega-3 fatty acids, which are widespread in extricate oils, exhibit insulin-sensitizing properties and can diminish diabetic complexities. Additionally, dietary texture—a plethora of whole grains and legumes—aids the level of glucose in blood management and pressure administration. Nutraceuticals offer further glycemic control; however, they still address the associated problems of diabetes. Antioxidant-rich vitamins, such as C and E, protect against oxidative stress, which is involved in diabetic complications. insulin. Furthermore, certain minerals, to a certain degree chromium and magnesium, play crucial roles in insulin, indicating oxygen absorption
Modern Medicine and Pharmaceutics Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed; Sambreen Zameer
International Journal of Integrative Sciences Vol. 3 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i4.8225

Abstract

Modern Medicine and pharmaceuticals have made tremendous strides in enhancing the healthcare and quality of life of people worldwide. This summary explores the key traits and trends in these fields. In recent decades, current medications have witnessed a paradigm shift toward personalized healthcare. Improvements in genomics, proteomics, and record analytics have paved the way for precision medication and tailoring treatments for an individual's genetic makeup. This technique enhances treatment efficacy while minimizing aspect consequences, marking a significant departure from the one-size-fits-all approach. Pharmaceutical research has experienced a revolution with the advent of biotechnology. Biopharmaceuticals, along with monoclonal antibodies and gene treatment plans, have emerged as powerful tools for the fight against formerly untreatable illnesses. Their ability to target specific molecules or genes has opened new frontiers in cancer treatment, uncommon illnesses, and autoimmune diseases. Furthermore, pharmaceutical enterprises have embraced virtual technologies. AI-pushed drug discovery, in silico medical trials, and telemedicine reshape the drug development pipeline and improve the care of affected persons. In particular, telemedicine has gained prominence, presenting available healthcare offerings and far-flung tracking. However, these advancements have moral and regulatory demands. Privateness issues, information protection, and equitable access to present-day remedies remain essential issues. The need for strong moral frameworks and regulatory oversight is paramount
Obesity Policy: Opportunities for Functional Food Market Growth Rehan Haider; Asghar Mehdi
International Journal of Applied Economics, Accounting and Management (IJAEAM) Vol. 1 No. 4 (2023): November 2023
Publisher : MultiTech Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59890/ijaeam.v1i4.912

Abstract

The all-encompassing rise in corpulence rates has prompted a reevaluation of community health tactics and has unlocked new opportunities in the food industry. This study investigates the dynamic connection between the corpulence procedures and growth of the working feed. By analyzing existing research, administration rules, and manufacturing trends, we aim to clear up these two rules and recognize potential avenues for cooperation. Public Health Crisis: Obesity has enhanced an urgent global change in well-being, accompanied by important socioeconomic and health-accompanying results. Governments have generally acknowledged the need for effective procedures to address this issue. The advertising of working meals, encompassing foodstuffs defending accompanying health-advancing elements, has knowledgeable important growth. Consumers pursue products that offer energy benefits beyond their fundamental food. Governments are presenting and strengthening tactics to combat corpulence. These include marking requirements, carbohydrate taxes, and limits on ballyhoo sick foods, forging two challenges and providing space for working food manufacturing. The demand for working snacks is growing in response to increased knowledge. As a result, there is prime freedom for working cooking manufacturers to join their product contributions that accompany the corpulence policy aims. The display of working foodstuffs is evolving rapidly, accompanied by changes in fruit development, including the inclusion of bioactive compounds and digestive augmentations to support weight administration and overall well-being. Collaboration between public health experts and working cuisine manufacturing could promote the production of more healthy output and more effective procedure exercises